| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |